Prescription drug · ANDA
Neomycin Sulfate NDC 73473-901
Neomycin sulfate 500 mg/1 · Tablet · Oral · Solaris Pharma Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73473-901-05 | 73473090105 | 100 TABLET in 1 BOTTLE, PLASTIC (73473-901-05)Marketed from Jun 1, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Neomycin Sulfate
- Generic name (nonproprietary)
- neomycin sulfate
- Active ingredients
- Neomycin sulfate — 500 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Solaris Pharma Corporation
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065220
- Marketing start
- Listing expires
- Other FDA classes
- Aminoglycosides (Chemical structure)
- Identifiers
- Product ID 73473-901_40441079-4a76-b56f-e063-6394a90a5765SPL ID 40441079-4a76-b56f-e063-6394a90a5765SPL set ID f430c5d9-ae82-3314-e053-2a95a90af04cRxCUI 866042UNII 057Y626693
- Pharmacologic class
- Aminoglycoside Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473473090105followed by a unit qualifier and the quantityPackage 73473-0901-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Neomycin Sulfate Tablets, USP and other antibacterial drugs, Neomycin Sulfate Tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Suppression of Intestinal Bacteria Neomycin Sulfate Tablets, USP are indicated as adjunctive therapy as part of…
Excerpt only. Read the full label for complete information.